Brendanp Eckelman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brendanp eckelman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brendanp Eckelman Today - Breaking & Trending Today

Insider Selling: Inhibrx, Inc. (NASDAQ:INBX) Insider Sells 300,000 Shares of Stock

Inhibrx, Inc. (NASDAQ:INBX – Get Free Report) insider Brendan P. Eckelman sold 300,000 shares of the business’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $34.30, for a total value of $10,290,000.00. Following the sale, the insider now directly owns 1,735,553 shares of the company’s stock, […] ....

United States , Brendanp Eckelman , Securities Exchange Commission , China Universal Asset Management Co , Inhibrx Inc , Inhibrx Company Profile , Quadrant Capital Group , Get Free Report , Exchange Commission , Capital Group , Universal Asset Management , Arizona State Retirement System , Inhibrx Daily ,

Inhibrx (NASDAQ:INBX) Trading Up 5.6%

Shares of Inhibrx, Inc. (NASDAQ:INBX – Get Rating) were up 5.6% on Friday . The stock traded as high as $20.77 and last traded at $20.73. Approximately 61,727 shares were traded during trading, a decline of 84% from the average daily volume of 396,952 shares. The stock had previously closed at $19.63. Wall Street Analysts […] ....

Mark Lappe , Brendanp Eckelman , Morgan Stanley , Squarepoint Ops , Voya Investment Management , Metlife Investment Management , Inhibrx Inc , Credit Suisse Group , Securities Exchange Commission , Get Rating , Suisse Group , Exchange Commission , Life Investment Management , Investment Management , Inhibrx Daily , Nasdaq Inbx ,

Inhibrx (NASDAQ:INBX) Shares Down 5.1%

Inhibrx, Inc. (NASDAQ:INBX – Get Rating) was down 5.1% during mid-day trading on Thursday . The company traded as low as $18.53 and last traded at $18.56. Approximately 89,389 shares were traded during trading, a decline of 78% from the average daily volume of 402,419 shares. The stock had previously closed at $19.56. Wall Street […] ....

Brendanp Eckelman , Mark Lappe , Metlife Investment Management , Squarepoint Ops , Credit Suisse Group , Securities Exchange Commission , Voya Investment Management , Hightower Advisors , Inhibrx Inc , Get Rating , Suisse Group , Stock Down , Exchange Commission , Life Investment Management , Investment Management , Tower Advisors , Amalgamated Bank , Inhibrx Daily , Nasdaq Inbx ,

IGM Biosciences (NASDAQ:IGMS) Trading Down 5.4%

Should You Buy or Sell Inhibrx Stock? Get The Latest INBX Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. ....

Brendanp Eckelman , Mark Lappe , Credit Suisse Group , Perceptive Advisors , Vanguard Group Inc , Blackrock Inc , Inhibrx Inc , Get Rating , Suisse Group , Street Corp , Vanguard Group , Inhibrx Daily ,

Inhibrx (NASDAQ:INBX) Trading Up 5.2%

Inhibrx, Inc. (NASDAQ:INBX – Get Rating)’s share price was up 5.2% during trading on Monday . The company traded as high as $20.48 and last traded at $20.31. Approximately 39,688 shares were traded during mid-day trading, a decline of 90% from the average daily volume of 408,404 shares. The stock had previously closed at $19.30. […] ....

Brendanp Eckelman , Inhibrx Company Profile , Credit Suisse Group , Vanguard Group Inc , Securities Exchange Commission , Inhibrx Inc , Perceptive Advisors , Blackrock Inc , Get Rating , Suisse Group , Exchange Commission , Street Corp , Vanguard Group , Inhibrx Daily , Nasdaq Inbx ,